logo

Quick Take: Healthways
By: Steve Alexander   Thursday, October 30, 2008 12:36 PM

Vote for next session
The next market session will close:

Healthways provides disease management services to health insurers, businesses, and the government. The company creates and implements plans of care focusing on a number of common conditions, such as diabetes or asthma. By providing doctors and patients with information, support plans (through telephone or Internet), and nurses who can guide and answer questions, Healthways aims to reduce overall medical costs to their clients. The value comes from savings in medical costs due to these programs outstripping the costs of signing a contract for Healthways' services. The company has several large clients ranging from Fortune 500 companies like McDonald's (MCD) to health insurance providers like Cigna (CI).

Up until 2008, Healthways had been enjoying outstanding growth. Revenues have grown at a 23% compound rate over the past 5 years, and operating earnings had followed suit at a 19% per year clip. Contract renewal rates have been very high, and Healthways protects against cancellations by generally signing long term (3-7 year) contracts. The business model itself is attractive economically. Providing nursing and informational resources is very low capital, allowing Healthways to produce an average 88.5% MFI return on capital, and 13.7% free cash flow margin over the trailing 5 year period. These increased earnings had allowed Healthways to increase it's business, signing on more plans, corporate clients, and even the government through Medicare and Medicaid pilots.

However, things have gone sour in 2008, and the problems being exposed this year are fundamental ones that could potentially cripple the business model. The very visible problem is with the Medicare pilot. The government agreed to, in effect, test drive Healthways' services and measure them to see if value was really being provided. The reward to the company was potentially very large if the government decided to implement the program widely. However, the risk was also large - if Healthways failed to meet Medicare's targets, it's failure would be public for all to see, including current and potential customers that may think twice before signing or renewing contracts. As of today, the news has been negative - Healthways has failed to meet Medicare targets up to this point.

This immediately makes the prospects for large government sales very dim. The spillover effect to existing customers has not yet played out, but it could as contracts come up for renewal. Corporate clients may decide to cut the expense of an effectively discretionary service to improve current earnings figures, given the difficult economy. Compounding the problem is the fact that most large health plans have the ability to provide Healthways' services in house - there is very little barrier to entry. Blue Cross Blue Shield of Minnesota recently did just this, opting not to renew it's contract with Healthways. This risk is magnified when one considers that 20% of Healthways' revenue comes from a single customer - Cigna, a health plan with plenty of ability to move services in house. The loss of Cigna would be a massive blow.

You would think that with such a risky situation, Healthways' would be conservative with it's capital. But that's not the case. The balance sheet is highly levered, with just $35 million of cash vs. $348 million of debt load. Interest coverage ratio is pretty tight at about 5 times operating earnings. That would concern me with a very stable company, and it alarms me with a company that relies on a revenue base that can vanish in a hurry.


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Special Offers
Partner Center
Recent Articles by Steve Alexander



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia